This site uses cookies to provide you with a more responsive and personalized service. By using this site and clicking on the "Accept" button, you agree to our use of cookies. Please read our Privacy Policy for more information on the types of cookies we use and how to delete or block them.
Learn more
At Johnson & Johnson our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow. We will combine our science and technology with our determination to create a powerful force of care ... and profoundly impact health for humanity.
Understand the pivotal role employers can play in enhancing the accessibility of Cell and Gene Therapies (CGTs) and recognize the significant advantages of incorporating CGT coverage into health plans.
Examine the patient journey gaining insights into before and after CGT treatment, enhancing compassionate healthcare practices. Obtain valuable insights from Johnson & Johnson leaders and partners on effective strategies in the CGT landscape.
Begin formulating a robust strategy to navigate the complexities of the CGT landscape in your organization. Access more resources and information at ThisIsCGT.com to enhance your understanding and implementation of CGT strategies.
Staying Ahead of Industry Trends: Understanding Cell and Gene Therapies (CGTs) is essential, as they represent the future of healthcare. Join this session to discover innovations that could impact your organization and its employees.
Enhance Employee Benefits: Incorporating CGT coverage in health plans can significantly improve health outcomes and productivity while attracting and retaining top talent in a competitive job market.
Navigate the Patient Journey: Understanding the patient's experience pre- and post-CGT treatment will empower you to support employees better, fostering a more compassionate healthcare environment.
Strategic Planning: Hear from leaders at Johnson & Johnson and their partners who possess firsthand experience in the CGT landscape. Start developing a strategic approach to integrate CGTs into your benefits offerings. You will leave equipped with practical tools, resources, and conversation starters for your carriers and consultants.
Speakers
Rita Johnson-Greene
COO
Alliance for Regenerative Medicine - Washington, DC
Rita Johnson-Greene is a seasoned healthcare executive who has a proven track record of building high-impact and collaborative organizations. She currently serves as the chief operating officer of the Alliance for Regenerative Medicine (ARM). Rita leads ARM's operations, finance, and global expansion initiatives to advance the development of engineered cell therapies and genetic medicines and promote access for all patients. Prior to ARM, Rita held leadership roles at bluebird bio and Spark Therapeutics, where she launched three of the first four gene therapies approved in the US. Rita also spent 10 years at AstraZeneca and has a background in finance, sales, commercial operations, and consulting.
Rita is committed to her faith and social impact. She leads a weekly Bible study and mentors young aspiring scientists. She serves on the GirlTrek Board, a community nonprofit that actively contributes to initiatives addressing healthcare disparities and youth empowerment. Rita also serves on the Drexel University BIOMED Dean's Executive Advisory Council and as a guest lecturer for the bio-medical graduate students.
Rita’s accolades, including Reuters Trailblazing Women in Pharma 2025, Drexel 100, Diversity MBA Magazine's Top 100 Women of Influence and Top 50 Under 50 Executives, and Working Mother Magazine's Working Mother of the Year, underscore her exemplary leadership and dedication to making a difference.